Companies / India
Chinese Champion To Threaten Indian Firms?
November 2006 | Industry NewsThe emergence of a 'Chinese Ranbaxy' in the coming years could spark consolidation in the Indian generics sector. Industry sources suggest that the Chinese government may construct the new entity by combining a number of state-owned firms, which will then go public.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
